MPT0B390
Product Specifications
UNSPSC Description
MPT0B390 is an arylsulfonamide-based derivative with potent HDAC inhibitory ability. MPT0B390, TIMP3 inducer, inhibits tumor growth, metastasis and angiogenesis. MPT0B390 shows antiproliferative activity against human colon cancer cell line HCT116 with the GI50 of 0.03 μM[1].
Target Antigen
HDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage;Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mpt0b390.html
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(NO)/C=C/C1=CN=C(N(S(=O)(C2=CC=C(OC)C=C2)=O)CC3)C3=C1
Molecular Weight
375.40
References & Citations
[1]Han-Li Huang, et al. TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis. Theranostics. 2019 Sep 18;9(22):6676-6689.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-145426/MPT0B390-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-145426/MPT0B390-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1817802-18-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1206591-01 0.02 mg (E-Coli)
Recombinant Pelodictyon phaeoclathratiforme HPr kinase/phosphorylase (hprK)
Ask
View Details MBS1206591-02 0.02 mg (Yeast)
Recombinant Pelodictyon phaeoclathratiforme HPr kinase/phosphorylase (hprK)
Ask
View Details 
MBS1206591-03 0.1 mg (E-Coli)
Recombinant Pelodictyon phaeoclathratiforme HPr kinase/phosphorylase (hprK)
Ask
View Details MBS1206591-04 0.1 mg (Yeast)
Recombinant Pelodictyon phaeoclathratiforme HPr kinase/phosphorylase (hprK)
Ask
View Details 
MBS1206591-05 0.02 mg (Baculovirus)
Recombinant Pelodictyon phaeoclathratiforme HPr kinase/phosphorylase (hprK)
Ask
View Details